Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN116640097B reveals metal-free sulfur-mediated cyclization for high-purity pharmaceutical intermediates. Enables cost reduction and scalable supply chain reliability.
Novel synthesis method offers high enantioselectivity and mild conditions for pharmaceutical intermediates manufacturing supply chain cost reduction and reliability improvements.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for scalable production of bioactive heterocycles.
Patent CN107973779A reveals mild Pd-catalyzed cyclization for indole derivatives. Enables cost reduction and scalable supply chain for pharmaceutical intermediate manufacturing globally.
Novel Mo/Cu co-catalyzed method offers mild conditions and high yields for scalable production of bioactive heterocycles.
Novel protonic acid catalysis reduces costs and improves supply chain reliability for high-purity pharmaceutical intermediates manufacturing globally.
Patent CN120172978B details a mild trifluoromethanesulfonic acid catalyzed method for dihydroquinolinopyrrole derivatives, offering cost reduction in pharmaceutical intermediate manufacturing and scalable supply chain solutions.
Novel patent CN121378226A reveals mild synthesis for oxindole compounds. Offers supply chain stability and cost efficiency for pharmaceutical intermediates manufacturing globally.
Novel one-pot Suzuki coupling method for Darolutamide intermediate. Eliminates column chromatography, reduces cost, ensures supply continuity for pharmaceutical manufacturing.
Patent CN119241450B reveals cost-effective route. Supply chain advantages.
Novel iron-catalyzed photochemical synthesis offers high yield and green chemistry advantages for pharmaceutical intermediates supply chain optimization.
Novel Cu-catalyzed cyclization for benzofuro[2,3-b]quinoline derivatives. High yield, mild conditions, cost-effective manufacturing for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for 2-trifluoromethyl quinazolinones. High yield, scalable route for API intermediates like Rutaecarpine.
Patent CN112480015B reveals a Pd-catalyzed carbonylation route for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable production capabilities.
Novel Pd-catalyzed C-H amination method for 2-aminoindole derivatives. Offers high efficiency, broad tolerance, and scalable commercial production capabilities.
Patent CN116589426B reveals iridium-catalyzed asymmetric synthesis enabling high-purity chiral intermediates with significant supply chain and cost advantages for global pharmaceutical manufacturing.
Novel palladium-catalyzed carbonylation method offers significant cost reduction in pharmaceutical intermediates manufacturing with high purity and scalable production capabilities for global supply chains.
Patent CN116813544B reveals a metal-free heating method for 2-trifluoromethyl quinoline. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediates supplier capabilities.
Patent CN114805209B details a metal-free photocatalytic route for 3-aryl-2H-indazoles, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN114478375A reveals a novel Pd-catalyzed route to 3-alkenyl quinolin-2(1H)ones using allyl aryl ethers, offering safer carbonylation and cost reduction in API manufacturing.